Chapter 6 Chromatin Remodeling and Nuclear Receptor Signaling

Progress in Molecular Biology and Translational Science

Volumn 87, Issue C, 2009, Pages 193-234

  Buranapramest, Manop ^a   Chakravarti, Debabrata ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CELL RECEPTOR; TRANSACTIVATOR PROTEIN;

ANIMAL; CHEMISTRY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLASSIFICATION; GENETICS; HUMAN; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 77957800880     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(09)87006-3     Document Type: Review

References (203)

1. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., et al. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835 9
2. Francis G.A., Fayard E., Picard F., and Auwerx J. Nuclear receptors and the control of metabolism. Annu Rev Physiol 65 (2003) 261-311
3. Overington J.P., Al-Lazikani B., and Hopkins A.L. How many drug targets are there?. Nat Rev Drug Discov 5 (2006) 993 6
4. Gronemeyer H., Gustafsson J.A., and Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 3 (2004) 950 64
5. Jensen E.V., and Jordan V.C. The estrogen receptor: a model for molecular medicine. Clin Cancer Res 9 (2003) 1980 9
6. Hollenberg S.M., Weinberger C., Ong E.S., Cerelli G., Oro A., Lebo R., et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318 (1985) 635 41
7. Htun H., Holth L.T., Walker D., Davie J.R., and Hager G.L. Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. Mol Biol Cell 10 (1999) 471 86
8. Tsai M.J., and O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63 (1994) 451 86
9. Umesono K., and Evans R.M. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 57 (1989) 1139 46
10. Glass C.K., and Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14 (2000) 121 41
11. Ribeiro R.C., Kushner P.J., Apriletti J.W., West B.L., and Baxter J.D. Thyroid hormone alters in vitro DNA binding of monomers and dimers of thyroid hormone receptors. Mol Endocrinol 6 (1992) 1142 52
12. Laudet V., and Adelmant G. Nuclear receptors. Lonesome orphans. Curr Biol 5 (1995) 124 7
13. Yin L., Wu N., Curtin J.C., Qatanani M., Szwergold N.R., Reid R.A., et al. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science 318 (2007) 1786 9
14. Raghuram S., Stayrook K.R., Huang P., Rogers P.M., Nosie A.K., McClure D.B., et al. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat Struct Mol Biol 14 (2007) 1207 13
15. Burris T.P. Nuclear hormone receptors for heme: REV-ERBalpha and REV-ERBbeta are ligand-regulated components of the mammalian clock. Mol Endocrinol 22 (2008) 1509 20
16. Benoit G., Malewicz M., and Perlmann T. Digging deep into the pockets of orphan nuclear receptors: insights from structural studies. Trends Cell Biol 14 (2004) 369 76
17. Bourguet W., Germain P., and Gronemeyer H. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol Sci 21 (2000) 381 8
18. Giguere V., Hollenberg S.M., Rosenfeld M.G., and Evans R.M. Functional domains of the human glucocorticoid receptor. Cell 46 (1986) 645 52
19. Kumar V., Green S., Stack G., Berry M., Jin J.R., and Chambon P. Functional domains of the human estrogen receptor. Cell 51 (1987) 941 51
20. Luisi B.F., Xu W.X., Otwinowski Z., Freedman L.P., Yamamoto K.R., and Sigler P.B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352 (1991) 497-505
21. Barettino D., Vivanco Ruiz M.M., and Stunnenberg H.G. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J 13 (1994) 3039 49
22. Danielian P.S., White R., Lees J.A., and Parker M.G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11 (1992) 1025 33
23. Durand B., Saunders M., Gaudon C., Roy B., Losson R., and Chambon P. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J 13 (1994) 5370 82
24. Chandra V., Huang P., Hamuro Y., Raghuram S., Wang Y., Burris T.P., et al. Structure of the intact PPAR-gamma-RXR-alpha nuclear receptor complex on DNA. Nature (2008) 350-356
25. Ing N.H., Beekman J.M., Tsai S.Y., Tsai M.J., and O'Malley B.W. Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J Biol Chem 267 (1992) 17617 23
26. Brou C., Wu J., Ali S., Scheer E., Lang C., Davidson I., et al. Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor. Nucleic Acids Res 21 (1993) 5-12
27. Klein-Hitpass L., Schwerk C., Kahmann S., and Vassen L. Targets of activated steroid hormone receptors: basal transcription factors and receptor interacting proteins. J Mol Med 76 (1998) 490 6
28. McKenna N.J., Xu J., Nawaz Z., Tsai S.Y., Tsai M.J., and O'Malley B.W. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol 69 (1999) 3-12
29. Kininis M., Isaacs G.D., Core L.J., Hah N., and Kraus W.L. Postrecruitment regulation of RNA polymerase II directs rapid signaling responses at the promoters of estrogen target genes. Mol Cell Biol 29 (2009) 1123 33
30. Belakavadi M., and Fondell J.D. Role of the mediator complex in nuclear hormone receptor signaling. Rev Physiol Biochem Pharmacol 156 (2006) 23-43
31. Onate S.A., Tsai S.Y., Tsai M.J., and O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270 (1995) 1354 7
32. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85 (1996) 403 14
33. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., et al. Role of CBP/P300 in nuclear receptor signalling. Nature 383 (1996) 99-103
34. Chen H., Lin R.J., Xie W., Wilpitz D., and Evans R.M. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98 (1999) 675 86
35. Shang Y., Hu X., DiRenzo J., Lazar M.A., and Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103 (2000) 843 52
36. Sharma D., and Fondell J.D. Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo. Proc Natl Acad Sci USA 99 (2002) 7934 9
37. Koh S.S., Chen D., Lee Y.H., and Stallcup M.R. Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J Biol Chem 276 (2001) 1089 98
38. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074 80
39. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41 5
40. Chen J., Kinyamu H.K., and Archer T.K. Changes in attitude, changes in latitude: nuclear receptors remodeling chromatin to regulate transcription. Mol Endocrinol 20 (2006) 1-13
41. Urnov F.D., and Wolffe A.P. A necessary good: nuclear hormone receptors and their chromatin templates. Mol Endocrinol 15 (2001) 1-16
42. Dilworth F.J., Fromental-Ramain C., Yamamoto K., and Chambon P. ATP-driven chromatin remodeling activity and histone acetyltransferases act sequentially during transactivation by RAR/RXR In vitro. Mol Cell 6 (2000) 1049 58
43. Fryer C.J., and Archer T.K. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 393 (1998) 88-91
44. Huang Z.Q., Li J., Sachs L.M., Cole P.A., and Wong J. A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription. EMBO J 22 (2003) 2146 55
45. Muchardt C., and Yaniv M. ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job. J Mol Biol 293 (1999) 187 98
46. Yoshinaga S.K., Peterson C.L., Herskowitz I., and Yamamoto K.R. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 258 (1992) 1598 604
47. Johnson C.N., Adkins N.L., and Georgel P. Chromatin remodeling complexes: ATP-dependent machines in action. Biochem Cell Biol 83 (2005) 405 17
48. Baniahmad A. Nuclear hormone receptor co-repressors. J Steroid Biochem Mol Biol 93 (2005) 89-97
49. Baniahmad A., Leng X., Burris T.P., Tsai S.Y., Tsai M.J., and O'Malley B.W. The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol Cell Biol 15 (1995) 76-86
50. Casanova J., Helmer E., Selmi-Ruby S., Qi J.S., Au-Fliegner M., Desai-Yajnik V., et al. Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol Cell Biol 14 (1994) 5756 65
51. Tong G.X., Jeyakumar M., Tanen M.R., and Bagchi M.K. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor. Mol Cell Biol 16 (1996) 1909 20
52. Chen J.D., and Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377 (1995) 454 7
53. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377 (1995) 397-404
54. Jepsen K., and Rosenfeld M.G. Biological roles and mechanistic actions of co-repressor complexes. J Cell Sci 115 (2002) 689 98
55. Privalsky M.L. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66 (2004) 315 60
56. Hu X., and Lazar M.A. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402 (1999) 93 6
57. Nagy L., Kao H.Y., Love J.D., Li C., Banayo E., Gooch J.T., et al. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev 13 (1999) 3209 16
58. Perissi V., Staszewski L.M., McInerney E.M., Kurokawa R., Krones A., Rose D.W., et al. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev 13 (1999) 3198 208
59. Cohen R.N., Brzostek S., Kim B., Chorev M., Wondisford F.E., and Hollenberg A.N. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains. Mol Endocrinol 15 (2001) 1049 61
60. Hu X., Li Y., and Lazar M.A. Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors. Mol Cell Biol 21 (2001) 1747 58
61. Ishizuka T., and Lazar M.A. The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor. Mol Cell Biol 23 (2003) 5122 31
62. Ordentlich P., Downes M., Xie W., Genin A., Spinner N.B., and Evans R.M. Unique forms of human and mouse nuclear receptor corepressor SMRT. Proc Natl Acad Sci USA 96 (1999) 2639 44
63. Guenther M.G., Barak O., and Lazar M.A. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol 21 (2001) 6091 101
64. Ishizuka T., and Lazar M.A. The nuclear receptor corepressor deacetylase activating domain is essential for repression by thyroid hormone receptor. Mol Endocrinol 19 (2005) 1443 51
65. Webb P., Anderson C.M., Valentine C., Nguyen P., Marimuthu A., West B.L., et al. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol Endocrinol 14 (2000) 1976 85
66. Hartman H.B., Yu J., Alenghat T., Ishizuka T., and Lazar M.A. The histone-binding code of nuclear receptor co-repressors matches the substrate specificity of histone deacetylase 3. EMBO Rep 6 (2005) 445 51
67. Yu J., Li Y., Ishizuka T., Guenther M.G., and Lazar M.A. A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation. EMBO J 22 (2003) 3403 10
68. Li J., Wang J., Nawaz Z., Liu J.M., Qin J., and Wong J. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J 19 (2000) 4342 50
69. Yoon H.G., Chan D.W., Huang Z.Q., Li J., Fondell J.D., Qin J., et al. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J 22 (2003) 1336 46
70. Zhang J., Kalkum M., Chait B.T., and Roeder R.G. The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol Cell 9 (2002) 611 23
71. Perissi V., Aggarwal A., Glass C.K., Rose D.W., and Rosenfeld M.G. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116 (2004) 511 26
72. Heinzel T., Lavinsky R.M., Mullen T.M., Soderstrom M., Laherty C.D., Torchia J., et al. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387 (1997) 43 8
73. Nagy L., Kao H.Y., Chakravarti D., Lin R.J., Hassig C.A., Ayer D.E., et al. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89 (1997) 373 80
74. Guenther M.G., Lane W.S., Fischle W., Verdin E., Lazar M.A., and Shiekhattar R. A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev 14 (2000) 1048 57
75. Li J., Lin Q., Wang W., Wade P., and Wong J. Specific targeting and constitutive association of histone deacetylase complexes during transcriptional repression. Genes Dev 16 (2002) 687 92
76. Jones P.L., Sachs L.M., Rouse N., Wade P.A., and Shi Y.B. Multiple N-CoR complexes contain distinct histone deacetylases. J Biol Chem 276 (2001) 8807 11
77. Huang E.Y., Zhang J., Miska E.A., Guenther M.G., Kouzarides T., and Lazar M.A. Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. Genes Dev 14 (2000) 45-54
78. Kao H.Y., Downes M., Ordentlich P., and Evans R.M. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev 14 (2000) 55-66
79. Farhana L., Dawson M.I., Leid M., Wang L., Moore D.D., Liu G., et al. Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor. Cancer Res 67 (2007) 318 25
80. Hu X., and Lazar M.A. Transcriptional repression by nuclear hormone receptors. Trends Endocrinol Metab 11 (2000) 6-10
81. Yoon H.G., Chan D.W., Reynolds A.B., Qin J., and Wong J. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol Cell 12 (2003) 723 34
82. Underhill C., Qutob M.S., Yee S.P., and Torchia J. A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1. J Biol Chem 275 (2000) 40463 70
83. Martens J.A., and Winston F. Evidence that Swi/Snf directly represses transcription in S. cerevisiae. Genes Dev 16 (2002) 2231 6
84. Alenghat T., Yu J., and Lazar M.A. The N-CoR complex enables chromatin remodeler SNF2H to enhance repression by thyroid hormone receptor. EMBO J 25 (2006) 3966 74
85. Ewing A.K., Attner M., and Chakravarti D. Novel regulatory role for human Acf1 in transcriptional repression of vitamin D3 receptor-regulated genes. Mol Endocrinol 21 (2007) 1791 806
86. Jepsen K., Hermanson O., Onami T.M., Gleiberman A.S., Lunyak V., McEvilly R.J., et al. Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 102 (2000) 753 63
87. Eickbush T.H., and Moudrianakis E.N. The histone core complex: an octamer assembled by two sets of protein-protein interactions. Biochemistry 17 (1978) 4955 64
88. Luger K., Mader A.W., Richmond R.K., Sargent D.F., and Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389 (1997) 251 60
89. Carruthers L.M., and Hansen J.C. The core histone N termini function independently of linker histones during chromatin condensation. J Biol Chem 275 (2000) 37285 90
90. Jiang C., and Pugh B.F. Nucleosome positioning and gene regulation: advances through genomics. Nat Rev Genet 10 (2009) 161 72
91. Khorasanizadeh S. The nucleosome: from genomic organization to genomic regulation. Cell 116 (2004) 259 72
92. Dorigo B., Schalch T., Bystricky K., and Richmond T.J. Chromatin fiber folding: requirement for the histone H4 N-terminal tail. J Mol Biol 327 (2003) 85-96
93. Zeng L., and Zhou M.M. Bromodomain: an acetyl-lysine binding domain. FEBS Lett 513 (2002) 124 8
94. Brehm A., Tufteland K.R., Aasland R., and Becker P.B. The many colours of chromodomains. Bioessays 26 (2004) 133 40
95. Bannister A.J., and Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 384 (1996) 641 3
96. Mizzen C.A., Yang X.J., Kokubo T., Brownell J.E., Bannister A.J., Owen-Hughes T., et al. The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell 87 (1996) 1261 70
97. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., and Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87 (1996) 953 9
98. Yang X.J., Ogryzko V.V., Nishikawa J., Howard B.H., and Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382 (1996) 319 24
99. Pokholok D.K., Harbison C.T., Levine S., Cole M., Hannett N.M., Lee T.I., et al. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122 (2005) 517 27
100. Roth S.Y., Denu J.M., and Allis C.D. Histone acetyltransferases. Annu Rev Biochem 70 (2001) 81-120
101. Hassig C.A., Fleischer T.C., Billin A.N., Schreiber S.L., and Ayer D.E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89 (1997) 341 7
102. Yang X.J. Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays 26 (2004) 1076 87
103. Hassan A.H., Prochasson P., Neely K.E., Galasinski S.C., Chandy M., Carrozza M.J., et al. Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes. Cell 111 (2002) 369 79
104. de la Cruz X., Lois S., Sanchez-Molina S., and Martinez-Balbas M.A. Do protein motifs read the histone code?. Bioessays 27 (2005) 164 75
105. Kutney S.N., Hong R., Macfarlan T., and Chakravarti D. A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression. J Biol Chem 279 (2004) 30850 5
106. Martin C., and Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6 (2005) 838 49
107. Jenuwein T., Laible G., Dorn R., and Reuter G. SET domain proteins modulate chromatin domains in eu- and heterochromatin. Cell Mol Life Sci 54 (1998) 80-93
108. Rea S., Eisenhaber F., O'Carroll D., Strahl B.D., Sun Z.W., Schmid M., et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406 (2000) 593 9
109. Aagaard L., Schmid M., Warburton P., and Jenuwein T. Mitotic phosphorylation of SUV39H1, a novel component of active centromeres, coincides with transient accumulation at mammalian centromeres. J Cell Sci 113 Pt 5 (2000) 817 29
110. Bannister A.J., Zegerman P., Partridge J.F., Miska E.A., Thomas J.O., Allshire R.C., et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410 (2001) 120 4
111. Lachner M., O'Carroll D., Rea S., Mechtler K., and Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410 (2001) 116 20
112. Nakayama J., Rice J.C., Strahl B.D., Allis C.D., and Grewal S.I. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 292 (2001) 110 3
113. Cao R., Wang L., Wang H., Xia L., Erdjument-Bromage H., Tempst P., et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298 (2002) 1039 43
114. Tachibana M., Sugimoto K., Nozaki M., Ueda J., Ohta T., Ohki M., et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 16 (2002) 1779 91
115. Chakravarti D., Ogryzko V., Kao H.Y., Nash A., Chen H., Nakatani Y., et al. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96 (1999) 393-403
116. Hamamori Y., Sartorelli V., Ogryzko V., Puri P.L., Wu H.Y., Wang J.Y., et al. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96 (1999) 405 13
117. Ait-Si-Ali S., Ramirez S., Barre F.X., Dkhissi F., Magnaghi-Jaulin L., Girault J.A., et al. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396 (1998) 184 6
118. Perissi V., Dasen J.S., Kurokawa R., Wang Z., Korzus E., Rose D.W., et al. Factor-specific modulation of CREB-binding protein acetyltransferase activity. Proc Natl Acad Sci USA 96 (1999) 3652 7
119. Seo S.B., McNamara P., Heo S., Turner A., Lane W.S., and Chakravarti D. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 104 (2001) 119 30
120. Seo S.B., Macfarlan T., McNamara P., Hong R., Mukai Y., Heo S., et al. Regulation of histone acetylation and transcription by nuclear protein pp32, a subunit of the INHAT complex. J Biol Chem 277 (2002) 14005 10
121. Loven M.A., Muster N., Yates J.R., and Nardulli A.M. A novel estrogen receptor alpha-associated protein, template-activating factor Ibeta, inhibits acetylation and transactivation. Mol Endocrinol 17 (2003) 67-78
122. Loven M.A., Davis R.E., Curtis C.D., Muster N., Yates J.R., and Nardulli A.M. A novel estrogen receptor alpha-associated protein alters receptor-deoxyribonucleic acid interactions and represses receptor-mediated transcription. Mol Endocrinol 18 (2004) 2649 59
123. Chakravarti D., and Hong R. SET-ting the stage for life and death. Cell 112 (2003) 589 91
124. Schultz-Norton J.R., Ziegler Y.S., Likhite V.S., Yates J.R., and Nardulli A.M. Isolation of novel coregulatory protein networks associated with DNA-bound estrogen receptor alpha. BMC Mol Biol 9 (2008) 97
125. Schneider R., Bannister A.J., Weise C., and Kouzarides T. Direct binding of INHAT to H3 tails disrupted by modifications. J Biol Chem 279 (2004) 23859 62
126. Ichijo T., Chrousos G.P., and Kino T. Activated glucocorticoid receptor interacts with the INHAT component Set/TAF-Ibeta and releases it from a glucocorticoid-responsive gene promoter, relieving repression: implications for the pathogenesis of glucocorticoid resistance in acute undifferentiated leukemia with Set-Can translocation. Mol Cell Endocrinol 283 (2008) 19-31
127. Adachi Y., Pavlakis G.N., and Copeland T.D. Identification and characterization of SET, a nuclear phosphoprotein encoded by the translocation break point in acute undifferentiated leukemia. J Biol Chem 269 (1994) 2258 62
128. Kular R.K., Cvetanovic M., Siferd S., Kini A.R., and Opal P. Neuronal differentiation is regulated by leucine-rich acidic nuclear protein (LANP), a member of the inhibitor of histone acetyltransferase complex. J Biol Chem 284 (2009) 7783 92
129. Fan Z., Zhang H., and Zhang Q. Tumor suppressor pp32 represses cell growth through inhibition of transcription by blocking acetylation and phosphorylation of histone H3 and initiating its proapoptotic activity. Cell Death Differ 13 (2006) 1485 94
130. Adegbola O., and Pasternack G.R. A pp32-retinoblastoma protein complex modulates androgen receptor-mediated transcription and associates with components of the splicing machinery. Biochem Biophys Res Commun 334 (2005) 702 8
131. Gamble M.J., Erdjument-Bromage H., Tempst P., Freedman L.P., and Fisher R.P. The histone chaperone TAF-I/SET/INHAT is required for transcription in vitro of chromatin templates. Mol Cell Biol 25 (2005) 797-807
132. Nagata K., Kawase H., Handa H., Yano K., Yamasaki M., Ishimi Y., et al. Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis. Proc Natl Acad Sci USA 92 (1995) 4279 83
133. Muto S., Senda M., Akai Y., Sato L., Suzuki T., Nagai R., et al. Relationship between the structure of SET/TAF-Ibeta/INHAT and its histone chaperone activity. Proc Natl Acad Sci USA 104 (2007) 4285 90
134. Fan H.Y., He X., Kingston R.E., and Narlikar G.J. Distinct strategies to make nucleosomal DNA accessible. Mol Cell 11 (2003) 1311 22
135. Jiang X., Kim H.E., Shu H., Zhao Y., Zhang H., Kofron J., et al. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299 (2003) 223 6
136. Fan Z., Beresford P.J., Oh D.Y., Zhang D., and Lieberman J. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 112 (2003) 659 72
137. Dirksen E.H., Cloos J., Braakhuis B.J., Brakenhoff R.H., Heck A.J., and Slijper M. Human lymphoblastoid proteome analysis reveals a role for the inhibitor of acetyltransferases complex in DNA double-strand break response. Cancer Res 66 (2006) 1473 80
138. Hong W., Kim A.Y., Ky S., Rakowski C., Seo S.B., Chakravarti D., et al. Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1. Mol Cell Biol 22 (2002) 3729 43
139. Ko S.I., Lee I.S., Kim J.Y., Kim S.M., Kim D.W., Lee K.S., et al. Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK. FEBS Lett 580 (2006) 3217 22
140. Jin C., Li H., Murata T., Sun K., Horikoshi M., Chiu R., et al. JDP2, a repressor of AP-1, recruits a histone deacetylase 3 complex to inhibit the retinoic acid-induced differentiation of F9 cells. Mol Cell Biol 22 (2002) 4815 26
141. Wardell S.E., Boonyaratanakornkit V., Adelman J.S., Aronheim A., and Edwards D.P. Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator. Mol Cell Biol 22 (2002) 5451 66
142. Nakade K., Pan J., Yoshiki A., Ugai H., Kimura M., Liu B., et al. JDP2 suppresses adipocyte differentiation by regulating histone acetylation. Cell Death Differ 14 (2007) 1398 405
143. Hublitz P., Kunowska N., Mayer U.P., Muller J.M., Heyne K., Yin N., et al. NIR is a novel INHAT repressor that modulates the transcriptional activity of p53. Genes Dev 19 (2005) 2912 24
144. Elgin S.C. DNAase I-hypersensitive sites of chromatin. Cell 27 (1981) 413 5
145. Gross D.S., and Garrard W.T. Nuclease hypersensitive sites in chromatin. Annu Rev Biochem 57 (1988) 159 97
146. McGhee J.D., Wood W.I., Dolan M., Engel J.D., and Felsenfeld G. A 200 base pair region at the 5′ end of the chicken adult beta-globin gene is accessible to nuclease digestion. Cell 27 (1981) 45-55
147. Yuan G.C., Liu Y.J., Dion M.F., Slack M.D., Wu L.F., Altschuler S.J., et al. Genome-scale identification of nucleosome positions in S. cerevisiae. Science 309 (2005) 626 30
148. Bernstein B.E., Liu C.L., Humphrey E.L., Perlstein E.O., and Schreiber S.L. Global nucleosome occupancy in yeast. Genome Biol 5 (2004) R62
149. Lee C.K., Shibata Y., Rao B., Strahl B.D., and Lieb J.D. Evidence for nucleosome depletion at active regulatory regions genome-wide. Nat Genet 36 (2004) 900 5
150. Chen X., Wang J., Woltring D., Gerondakis S., and Shannon M.F. Histone dynamics on the interleukin-2 gene in response to T-cell activation. Mol Cell Biol 25 (2005) 3209 19
151. Vicent G.P., Nacht A.S., Smith C.L., Peterson C.L., Dimitrov S., and Beato M. DNA instructed displacement of histones H2A and H2B at an inducible promoter. Mol Cell 16 (2004) 439 52
152. Brown D.D. The role of stable complexes that repress and activate eucaryotic genes. Cell 37 (1984) 359 65
153. Segal E., Fondufe-Mittendorf Y., Chen L., Thastrom A., Field Y., Moore I.K., et al. A genomic code for nucleosome positioning. Nature 442 (2006) 772 8
154. Boeger H., Griesenbeck J., Strattan J.S., and Kornberg R.D. Nucleosomes unfold completely at a transcriptionally active promoter. Mol Cell 11 (2003) 1587 98
155. Reinke H., and Horz W. Histones are first hyperacetylated and then lose contact with the activated PHO5 promoter. Mol Cell 11 (2003) 1599 607
156. Chandy M., Gutierrez J.L., Prochasson P., and Workman J.L. SWI/SNF displaces SAGA-acetylated nucleosomes. Eukaryot Cell 5 (2006) 1738 47
157. Zhang Y., Shin H., Song J.S., Lei Y., and Liu X.S. Identifying positioned nucleosomes with epigenetic marks in human from ChIP-Seq. BMC Genomics 9 (2008) 537
158. Schones D.E., Cui K., Cuddapah S., Roh T.Y., Barski A., Wang Z., et al. Dynamic regulation of nucleosome positioning in the human genome. Cell 132 (2008) 887 98
159. Schones D.E., and Zhao K. Genome-wide approaches to studying chromatin modifications. Nat Rev Genet 9 (2008) 179 91
160. Dressel U., Thormeyer D., Altincicek B., Paululat A., Eggert M., Schneider S., et al. Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol Cell Biol 19 (1999) 3383 94
161. Eckey M., Hong W., Papaioannou M., and Baniahmad A. The nucleosome assembly activity of NAP1 is enhanced by Alien. Mol Cell Biol 27 (2007) 3557 68
162. Kingston R.E., and Narlikar G.J. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev 13 (1999) 2339 52
163. Saha A., Wittmeyer J., and Cairns B.R. Chromatin remodelling: the industrial revolution of DNA around histones. Nat Rev Mol Cell Biol 7 (2006) 437 47
164. Eberharter A., and Becker P.B. ATP-dependent nucleosome remodelling: factors and functions. J Cell Sci 117 (2004) 3707 11
165. Becker P.B., and Horz W. ATP-dependent nucleosome remodeling. Annu Rev Biochem 71 (2002) 247 73
166. Peterson C.L., and Logie C. Recruitment of chromatin remodeling machines. J Cell Biochem 78 (2000) 179 85
167. Neigeborn L., and Carlson M. Genes affecting the regulation of SUC2 gene expression by glucose repression in Saccharomyces cerevisiae. Genetics 108 (1984) 845 58
168. Stern M., Jensen R., and Herskowitz I. Five SWI genes are required for expression of the HO gene in yeast. J Mol Biol 178 (1984) 853 68
169. Peterson C.L., and Herskowitz I. Characterization of the yeast SWI1, SWI2, and SWI3 genes, which encode a global activator of transcription. Cell 68 (1992) 573 83
170. Peterson C.L., and Tamkun J.W. The SWI-SNF complex: a chromatin remodeling machine?. Trends Biochem Sci 20 (1995) 143 6
171. Martens J.A., and Winston F. Recent advances in understanding chromatin remodeling by Swi/Snf complexes. Curr Opin Genet Dev 13 (2003) 136 42
172. Reyes J.C., Muchardt C., and Yaniv M. Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix. J Cell Biol 137 (1997) 263 74
173. Aoyagi S., and Archer T.K. Dynamics of coactivator recruitment and chromatin modifications during nuclear receptor mediated transcription. Mol Cell Endocrinol 280 (2008) 1-5
174. Hebbar P.B., and Archer T.K. Chromatin remodeling by nuclear receptors. Chromosoma 111 (2003) 495-504
175. Trotter K.W., and Archer T.K. Nuclear receptors and chromatin remodeling machinery. Mol Cell Endocrinol 265-266 (2007) 162 7
176. Muchardt C., and Yaniv M. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J 12 (1993) 4279 90
177. Acevedo M.L., and Kraus W.L. Transcriptional activation by nuclear receptors. Essays Biochem 40 (2004) 73-88
178. Archer T.K., Lefebvre P., Wolford R.G., and Hager G.L. Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation. Science 255 (1992) 1573 6
179. Beato M., and Eisfeld K. Transcription factor access to chromatin. Nucleic Acids Res 25 (1997) 3559 63
180. Ichinose H., Garnier J.M., Chambon P., and Losson R. Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2. Gene 188 (1997) 95-100
181. Trotter K.W., and Archer T.K. Reconstitution of glucocorticoid receptor-dependent transcription in vivo. Mol Cell Biol 24 (2004) 3347 58
182. Belandia B., and Parker M.G. Nuclear receptors: a rendezvous for chromatin remodeling factors. Cell 114 (2003) 277 80
183. Chiba H., Muramatsu M., Nomoto A., and Kato H. Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res 22 (1994) 1815 20
184. Kitagawa H., Fujiki R., Yoshimura K., Mezaki Y., Uematsu Y., Matsui D., et al. The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 113 (2003) 905 17
185. Fujiki R., Kim M.S., Sasaki Y., Yoshimura K., Kitagawa H., and Kato S.
186. Ito T., Bulger M., Pazin M.J., Kobayashi R., and Kadonaga J.T. ACF, an ISWI-containing and ATP-utilizing chromatin assembly and remodeling factor. Cell 90 (1997) 145 55
187. Varga-Weisz P.D., Wilm M., Bonte E., Dumas K., Mann M., and Becker P.B. Chromatin-remodelling factor CHRAC contains the ATPases ISWI and topoisomerase II. Nature 388 (1997) 598-602
188. Bochar D.A., Savard J., Wang W., Lafleur D.W., Moore P., Cote J., et al. A family of chromatin remodeling factors related to Williams syndrome transcription factor. Proc Natl Acad Sci USA 97 (2000) 1038 43
189. Fyodorov D.V., Blower M.D., Karpen G.H., and Kadonaga J.T. Acf1 confers unique activities to ACF/CHRAC and promotes the formation rather than disruption of chromatin in vivo. Genes Dev 18 (2004) 170 83
190. Goldmark J.P., Fazzio T.G., Estep P.W., Church G.M., and Tsukiyama T. The Isw2 chromatin remodeling complex represses early meiotic genes upon recruitment by Ume6p. Cell 103 (2000) 423 33
191. Fazzio T.G., and Tsukiyama T. Chromatin remodeling in vivo: evidence for a nucleosome sliding mechanism. Mol Cell 12 (2003) 1333 40
192. Moreau J.L., Lee M., Mahachi N., Vary J., Mellor J., Tsukiyama T., et al. Regulated displacement of TBP from the PHO8 promoter in vivo requires Cbf1 and the Isw1 chromatin remodeling complex. Mol Cell 11 (2003) 1609 20
193. Whitehouse I., and Tsukiyama T. Antagonistic forces that position nucleosomes in vivo. Nat Struct Mol Biol 13 (2006) 633 40
194. Stopka T., and Skoultchi A.I. The ISWI ATPase Snf2h is required for early mouse development. Proc Natl Acad Sci USA 100 (2003) 14097 102
195. Liu Y.I., Chang M.V., Li H.E., Barolo S., Chang J.L., Blauwkamp T.A., et al. The chromatin remodelers ISWI and ACF1 directly repress Wingless transcriptional targets. Dev Biol 323 (2008) 41-52
196. Di Croce L., Koop R., Venditti P., Westphal H.M., Nightingale K.P., Corona D.F., et al. Two-step synergism between the progesterone receptor and the DNA-binding domain of nuclear factor 1 on MMTV minichromosomes. Mol Cell 4 (1999) 45-54
197. Badenhorst P., Xiao H., Cherbas L., Kwon S.Y., Voas M., Rebay I., et al. The Drosophila nucleosome remodeling factor NURF is required for Ecdysteroid signaling and metamorphosis. Genes Dev 19 (2005) 2540 5
198. Eberharter A., Ferrari S., Langst G., Straub T., Imhof A., Varga-Weisz P., et al. Acf1, the largest subunit of CHRAC, regulates ISWI-induced nucleosome remodelling. EMBO J 20 (2001) 3781 8
199. Eberharter A., Vetter I., Ferreira R., and Becker P.B. ACF1 improves the effectiveness of nucleosome mobilization by ISWI through PHD-histone contacts. EMBO J 23 (2004) 4029 39
200. Collins N., Poot R.A., Kukimoto I., Garcia-Jimenez C., Dellaire G., and Varga-Weisz P.D. An ACF1-ISWI chromatin-remodeling complex is required for DNA replication through heterochromatin. Nat Genet 32 (2002) 627 32
201. Zhou Y., and Grummt I. The PHD finger/bromodomain of NoRC interacts with acetylated histone H4K16 and is sufficient for rDNA silencing. Curr Biol 15 (2005) 1434 8
202. Zhou Y., Santoro R., and Grummt I. The chromatin remodeling complex NoRC targets HDAC1 to the ribosomal gene promoter and represses RNA polymerase I transcription. EMBO J 21 (2002) 4632 40
203. Wang X., Arai S., Song X., Reichart D., Du K., Pascual G., Tempst P., Rosenfeld M.G., Glass C.K., and Kurokawa R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 454 (2008) 126 30